Valon Lasers

Valon Lasers has crafted ophthalmic lasers for treatment of diabetic retinopathy, a major cause for blindness in developed countries


Valon Lasers main products, 532nm pattern scanning photocoagulators Valon 5G and Valon TT, are developed mainly for treatment of diabetic retinopathy – a major cause for blindness in developed countries if left untreated. The team behind Valon Lasers has crafted and developed innovative ophthalmic lasers since 1972. All the development and production work is crafted in Vantaa, Finland at Valon Lasers’ headquarters.

Inventure joined Valon Lasers in 2011.


Do you want to learn how to collaborate with one of the world’s biggest healthcare companies or pitch your idea to a VC with an extensive health tech investments portfolio? Join us at the pre-Slush event with @pfizer and @inventureVC #slush18 #pharma #vc

Denmark, Finland, Iceland, Norway, Sweden. 🇩🇰 🇫🇮 🇮🇸 🇳🇴 🇸🇪

Make sure the individuals who are doing great things in your ecosystem are recognised in this year's The Nordic 100, nominations are open NOW!

#cphftw #sthlmtech #helyes

Register here: